Hemas Holdings
科伦坡医疗保健和个人护理集团，拥有区域药品分销权。
Hemas Holdings 是一家斯里兰卡企业集团，拥有医疗保健和消费品部门。其快速消费品部门成立于 1948 年，生产个人护理产品（Baby Cheramy、Clogard），其医疗保健部门在南亚和东南亚分销药品。
- Type
- Manufacturer
- Location
- Colombo, Sri Lanka
- Founded
- 1948
- Website
- hemas.com
- Categories
- 医疗保健用品, 个人护理
- Markets
- 孟加拉国, 巴基斯坦, 马来西亚, 阿拉伯联合酋长国
Verified facts
- lei-lapsed (amber), checked 2026-08-08 GLEIF
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- domain-registered (green), checked 2026-08-08 Domain registry record
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
Import rules for these goods
- Cosmetic products must be notified in the EU Cosmetic Products Notification Portal (CPNP) before being placed on the EU market. European Commission (CPNP)
- For the US market, MoCRA requires cosmetic facility registration and product listing with the FDA. US FDA (MoCRA)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)